
Overview
Dr. Jason Chan is a radiation oncologist who specializes in treating head and neck cancers as well as thoracic cancer (cancers of the chest, including lung cancer). Chan has expertise in the full range of modern radiation therapy techniques, including intensity-modulated radiation therapy (which delivers precise radiation doses to a tumor or specific areas within the tumor), stereotactic radiotherapy (which uses particularly precise radiation doses and calls for fewer doses than traditional therapy), intraoperative radiotherapy (delivery of a large dose during surgery) and brachytherapy (in which a radiation source is placed inside the body). Chan earned his medical degree at the Warren Alpert Medical School of Brown University. He completed a residency in radiation oncology at UCSF, serving as chief resident. He then completed a fellowship in head and neck cancer at UCSF.
Dr. Chan is highly rated in 17 conditions, according to our data. His top areas of expertise are Nasopharyngeal Carcinoma, Olfactory Neuroblastoma, Teratocarcinosarcoma, and Thyroid Cancer.
His clinical research consists of co-authoring 61 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1600 Divisadero St., Basement Level, San Francisco, CA 94115
1825 Fourth St., First Floor, Room L1101, San Francisco, CA 94158
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Adult Neurofibromatosis Type 1 (NF1) And Schwannomatosis Clinic
Dr. David Raleigh is a radiation oncologist who specializes in brain tumors. He cares for both adult and pediatric patients. Raleigh's research focuses on understanding the biological processes that cause brain tumors to grow. His goals are to uncover new measures of brain cancer and to identify cells for drugs to target. Raleigh earned a bachelor's degree in molecular and cell biology as well as a bachelor's degree in cognitive science from the University of California, Berkeley. He earned his doctoral degree in molecular pathogenesis – how disease develops at the molecular level – from the University of Chicago, followed by his medical degree from the Pritzker School of Medicine at the University of Chicago. He completed a residency in radiation oncology at UCSF. Raleigh is a member of the American Society of Clinical Oncology, American Society for Radiation Oncology, Pacific Pediatric Neuro-Oncology Consortium, Children's Oncology Group, Society for Neuro-Oncology, International Meningioma Society and North American Skull Base Society. At the UCSF Brain Tumor Center, Raleigh is a principal investigator with the Wolfe Meningioma Program Project. Dr. Raleigh is highly rated in 22 conditions, according to our data. His top areas of expertise are Meningioma, Pineocytoma, Brain Tumor, and Gliomatosis Cerebri.
Melanoma & Skin Cancer Center
Dr. Sue Yom is an expert in the radiation treatment and management of head, neck and lung cancers. In her research, Yom studies chemoradiation (a combination of chemotherapy and radiation) for these cancers. She also investigates image-guided radiation therapy and ways to reduce toxic effects using focused radiation techniques, emerging biological agents and radiation protectants. Yom earned her medical and doctoral degrees at the University of Pennsylvania. She completed a residency in radiation oncology at the MD Anderson Cancer Center. Yom has received numerous awards recognizing her commitment to patient care and patient-oriented research. Dr. Yom is highly rated in 28 conditions, according to our data. Her top areas of expertise are Nasopharyngeal Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Merkel Cell Carcinoma, and Olfactory Neuroblastoma.
Stanford Health Care
Richard Hoppe is a Radiation Oncologist in Stanford, California. Dr. Hoppe is highly rated in 15 conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Mycosis Fungoides, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Cutaneous T-Cell Lymphoma (CTCL).
Frequently Asked Questions about Dr. Jason Chan
How do I make an appointment with Dr. Jason Chan?
You can book an appointment with Dr. Jason Chan by calling their office at 415-353-7175. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jason Chan a top-rated expert for Nasopharyngeal Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jason Chan is classified as an Distinguished expert for Nasopharyngeal Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jason Chan specialize in?
While Dr. Jason Chan is a Radiation Oncology, they have specific expertise in Nasopharyngeal Carcinoma, Olfactory Neuroblastoma, and Teratocarcinosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Jason Chan participate in research or clinical trials?
Yes. Dr. Jason Chan has published 61 articles and abstracts on conditions like Nasopharyngeal Carcinoma. You can view a list of Dr. Jason Chan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jason Chan accept my insurance?
Dr. Jason Chan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-353-7175 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Nasopharyngeal CarcinomaDr. Chan isDistinguished. Learn about Nasopharyngeal Carcinoma.
- Olfactory NeuroblastomaDr. Chan isDistinguished. Learn about Olfactory Neuroblastoma.
- TeratocarcinosarcomaDr. Chan isDistinguished. Learn about Teratocarcinosarcoma.
- Advanced
- Adenoid Cystic CarcinomaDr. Chan isAdvanced. Learn about Adenoid Cystic Carcinoma.
- Anaplastic Thyroid CancerDr. Chan isAdvanced. Learn about Anaplastic Thyroid Cancer.
- Epithelial-Myoepithelial Carcinoma
- Familial Prostate CancerDr. Chan isAdvanced. Learn about Familial Prostate Cancer.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- MelanomaDr. Chan isAdvanced. Learn about Melanoma.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- ALK-Positive Non-Small Cell Lung Cancer
- Alveolar Soft Part SarcomaDr. Chan isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Angiosarcoma of the ScalpDr. Chan isExperienced. Learn about Angiosarcoma of the Scalp.
- Arteriovenous MalformationDr. Chan isExperienced. Learn about Arteriovenous Malformation.
- Bone TumorDr. Chan isExperienced. Learn about Bone Tumor.


